Work

Table S2 from Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant

Year: 2023

Type: other

Abstract: Table S2. Highly expressed loci in COH-SC31 in relation to COH-SC1

DOI: 10.1158/1078-0432.22467278.v1

Authors: Pei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya, Karineh Petrossian, Hang-Kai Hsu, Duc Nguyen, Daniel Schmolze, Masaya Kai, Chun-Yu Liu, Hannah Lu, Peiguo Chu, Courtney A. Vito, Laura Kruper, Joanne Mortimer, Shiuan Chen

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361929427

Cites:

Cited by:

Related to: 10